Phosphoprotein Associated with Glycosphingolipid-Enriched Microdomains Differentially Modulates Src Kinase Activity in Brain Maturation by Lindquist, Sabine et al.
Phosphoprotein Associated with Glycosphingolipid-
Enriched Microdomains Differentially Modulates Src
Kinase Activity in Brain Maturation
Sabine Lindquist
1,2*, Diana Karitkina
2, Kristina Langnaese
3, Anita Posevitz-Fejfar
4¤, Burkhart
Schraven
4,5, Ramnik Xavier
6, Brian Seed
6, Jonathan A. Lindquist
4
1Department of Neurology, Hannover Medical School, Hannover, Germany, 2Leibniz Institute for Neurobiology, Magdeburg, Germany, 3Institute for Biochemistry and
Cell Biology, Otto-von-Guericke University, Magdeburg, Germany, 4Institute of Molecular and Clinical Immunology, Otto-von-Guericke University, Magdeburg, Germany,
5Department of Immune Control, Helmholtz Centre for Infection Research, Braunschweig, Germany, 6Center for Computational and Integrative Biology, Massachusetts
General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
Abstract
Src family kinases (SFK) control multiple processes during brain development and function. We show here that the
phosphoprotein associated with glycosphigolipid-enriched microdomains (PAG)/Csk binding protein (Cbp) modulates SFK
activity in the brain. The timing and localization of PAG expression overlap with Fyn and Src, both of which we find
associated to PAG. We demonstrate in newborn (P1) mice that PAG negatively regulates Src family kinases (SFK). P1 Pag1
-/-
mouse brains show decreased recruitment of Csk into lipid rafts, reduced phosphorylation of the inhibitory tyrosines within
SFKs, and an increase in SFK activity of ./=50%. While in brain of P1 mice, PAG and Csk are highly and ubiquitously
expressed, little Csk is found in adult brain suggesting altered modes of SFK regulation. In adult brain Pag1-deficiency has
no effect upon Csk-distribution or inhibitory tyrosine phosphorylation, but kinase activity is now reduced (220–30%),
pointing to the development of a compensatory mechanism that may involve PSD93. The distribution of the Csk-
homologous kinase CHK is not altered. Importantly, since the activities of Fyn and Src are decreased in adult Pag1
-/- mice,
thus presenting the reversed phenotype of P1, this provides the first in vivo evidence for a Csk-independent positive
regulatory function for PAG in the brain.
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Introduction
Src family kinases (SFK) play key roles in regulating the cell
cycle, differentiation, cell-cell contact, and receptor activation in
various cell types [1]. The expression pattern and developmental
regulation of SFKs in the central nervous system are partly
overlapping and analysis of knockout mice demonstrated consid-
erable redundancy among the SFKs, but also some unique
functions. Specifically, Fyn-deficient mice show alterations in the
neuronal architecture of the hippocampus and are hypomyeli-
nated [2–4]. Functional deficits include impaired long-term
potentiation and spatial learning, increased anxiety, and a higher
sensitivity to ethanol [2,5,6]. Interestingly, Fyn-knockout mice
compensate by upregulating the activity of Src, specifically in the
Triton-X-insoluble fractions [7,8]. The importance of Fyn and Src
redundancy is highlighted in Src
-/-/Fyn
-/- double-knockout mice of
which 85–90% die perinatally and Src
-/--Fyn
-/--Yes
-/--triple-mu-
tants which all die early in gestation [7,9].
Src family kinases are targeted to the membrane by lipid
modifications of their N-terminus and their kinase activity is
regulated by phosphorylation. While phosphorylation of tyrosine
418 (Y418 human Src) within the kinase domain is associated with
activation, phosphorylation of tyrosine 529 (Y529 human Src) in
the regulatory C-terminus allows intramolecular binding to the
SH2-domain, resulting in a closed-inactive conformation [10]. Csk
was the first kinase identified to phosphorylate Y529 [11]. In Csk-
knockout mice the activity of Src, Fyn, and Lyn is constitutively
enhanced [12]. The generalized dysregulation of Src kinase
activity causes an embryonically lethal phenotype with gross
neural tube defects and dramatic neuronal cell death [12,13]. Csk
is highly expressed during development, but expression in brain
rapidly declines after birth. Its homologue, CHK (Csk-homologous
kinase) also phosphorylates Y529 and shows the opposite expre-
ssion pattern, increasing in abundance in adult brain. Both Csk and
CHK lack the lipid modification necessary for association to the
membrane compartment where Src kinases reside. Brdicka et al.
[14] and Kawabuchi et al. [15] both identified PAG (phosphopro-
tein associated with glycosphingolipid-enriched microdomains)/
Cbp (Csk-binding protein) as a molecule that recruits Csk to the
plasma membrane and into lipid rafts. The function of PAG was
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to constitutively bindPAG [14]. Phosphorylationof Y314 inmurine
PAG (Y317 in human) by SFK allows the SH2 domain of Csk to
bind and thus recruits Csk into the lipid rafts where it inhibits Src
kinases. Upon T-cell receptor activation, PAG becomes rapidly
dephosphorylated, Csk binding is lost, and Fyn is activated via
dephosphorylation of Y529 and autophosphorylation of Y418.
Active Fyn then rephosphorylates PAG, recruiting Csk, and thus
terminating the signal (reviewed in [16]). This model could
subsequently be extended to the control of Lyn kinase activity in
FceRI signaling [17,18] and Src and Yes activity upon EGF-
receptorstimulation[19]aswell astothe regulationofadhesionand
migration of embryonal fibroblasts [20].
The PAG-Csk-complex was originally isolated from the brain
of newborn rats where Fyn is primarily responsible for PAG
phosphorylation [15,20], and a role in brain development is
suggested by our recent study in a mouse model of muscular
dystrophy. These a2-Laminin-deficient mice show delayed oligo-
dendrocyte maturation associated with an increase in phosphor-
ylation of the inhibitory Y529 in Fyn, which correlates well with an
increased expression of PAG and Csk in cortices of 3 weeks old
mice [21].
In the current study, we demonstrate that PAG is necessary for
the recruitment of Csk and thus inhibition of SFK activity in
postnatal brain, but functions Csk-independently as a positive
regulator of SFK in brains of adult mice.
Materials and Methods
Antibodies and reagents
Rabbit phosphor-specific anti-Src (pY418), recognizing both
Y423 in mouse Src and Y419 in mouse Fyn, as well as anti-Src
(pY529), recognizing both Y534 in mouse Src and Y530 in mouse
Fyn due to the highly conserved sequence of these residues [22]
were purchased from BioSource, rabbit anti-Csk (C-20) and anti-
Ctk from Santa Cruz, mouse-anti-Csk (clone 52) and mouse anti-
CHK from BD BioSciences, mouse anti-Src (clone GD11) from
Upstate (Lake Placid, NY), rabbit anti-PSD93 from Alomone Labs
Ltd., rabbit anti-c-Src (Y215) from ECM Biosciences, and mouse
anti-b-actin (clone AC-15) from Sigma. Mouse-anti-phosphotyr-
osine (4G10) antibodies were produced in our institute from the
hybridoma cells. Secondary antibodies goat-anti-mouse-HRP and
goat-anti-rabbit-HRP were obtained from Dianova.
Rabbit polyclonal anti-PAG (residues 97-432) and mouse anti-
Fyn (Fyn 02) were kindly provided by Vaclav Horejsi (Prague,
CZ). Anti-phospho-PAG (pY317/pY314) was developed by
Burkhart Schraven [23]. Rabbit polyclonal anti-PAG (Ig452)
against the peptide CGDLQQGRDVTRL was developed in
collaboration with ImmunoGlobe (Berlin, Germany). The anti-
bodies against PAG, Fyn and Src used here recognize the
respective proteins phospho-independently (Fig. S1). Chemicals
were purchased from Sigma unless stated otherwise.
Pag1-knockout mice
Mice with a deletion in the Pag1 gene were generated using
modified bacterial artificial chromosome (BAC) technology as
previously described [24]. In brief, we obtained BAC clones
spanning the Pag1 locus from Research Genetics (Invitrogen Life
Technologies). Two short sequences flanking exons 6 were cloned
into the 59 and 39 insertion sites of the selection cassette of the
pSKY replacement vector. BAC host cells were transformed with
the pBADred plasmid, which helped produce electroporation-
competent cells. The linear fragment released from the pSKY
backbone was then electroporated into the BAC host, and the
transformants were selected for simultaneous resistance to
chloramphenicol (from the BAC backbone) and zeocin (from the
insert). The resulting mutant BAC is shown in Fig. S2A.
As shown in Fig. S2B, PAG1/PAG2/Pzeo primers (pag1:
ttctttcagaagacagcacgctg; pag2: gcgtccaccggtcccttctgcag), identify a
predicted 473-bp PCR product in the mutant BAC confirming 59
targeting. As predicted, the Psv/PAG1/PAG2 primers identify a
745-bp PCR product in the mutant BAC and 581-bp PCR
product in the wild-type BAC. Restriction digestion with BamHI
and HindIII confirms the identity of WT and mutant BACs (Fig.
S2C). Fluorescence in situ hybridization was performed as
described previously and confirmed targeting in clones 7 and 35
(Fig. S2D). Pag1
–/– mice from clone 7 were born in the expected
Mendelian frequency of 25% in Pag1
+/2 crossings with a male/
female ratio of 1:1. In Pag1
-/- breedings the male/female ratio was
1:0.94 (66 animals analyzed). All experiments were performed on
tissue from euthanized animals in accordance with the German
National Guidelines for the Use of Experimental Animals (Animal
Protection Act, Tierschutzgesetz, TierSchG, in particular para-
graph 7 and 8). Animals were handled in accordance with the
European Communities Council Directive 86/609/EEC. All
possible efforts were made to minimize animal suffering and the
number of animals used.
In situ-hybridization
In situ-hybridization was carried out on 18- mm-thick cryosec-
tions of mouse brains as previously described [25,26]. For the
antisense-probe, a pBluescript II SK plasmid containing the
complete mouse PAG cDNA (accession number AF250192) [14]
was linearized with BamHI (internal BamHI site), in vitro
transcribed with T7 RNA polymerase yielding a cRNA of ,900
bases. To produce sense cRNA for control the plasmid was
linearized with Hind III, yielding a ,800 bases long antisense
cRNA (internal HindIII site); the cRNA was in vitro transcribed
with T3 RNA polymerase. The specific activity of the probes was
,10
8 cpm/mg. Radioactivity was adjusted to 3,3610
6 cpm/
100 ml hybridization buffer and used immediately. The slides
were dipped, developed, and counterstained Mayer’s hematoxylin
solution and eosin as previously described.
RNA extraction
RNA was isolated from whole brains of C57Blc6 mice at the
indicated age (except E12: whole embryo head) using peqGOLD
TriFast according to the manufacturer’s instructions (Peqlab,
Erlangen, Germany). RNA samples were dissolved in water and
quantified spectrophotometrically at 260 nm. After treatment with
TURBO-DNase (TURBO DNA-freeTM, Ambion Inc.) according
to the manufacturer’s instructions, 2 mg of total RNA were
transcribed into cDNA using RevertAidTM H Minus M-MuLV
Reverse Transcriptase and the RevertAidTM H Minus First
Strand cDNA Synthesis Kit according to manufacturer’s instruc-
tions (Fermentas).
RT-PCR
Primer sequences were designed to span intron regions to insure
that no false positive PCR fragments would be generated from
pseudogenes in the contaminating genomic DNA. The following
primers were used:
PAG-r (AGTTCCTTGTCATACAAGTCTCG),
PAG-f (CCACTTCTGCCTTGAAGGAGCTTC),
Fyn-r (TGGCACAGGAGCAGCTATTTA C),
Fyn-f (GAGCTGGTCACCAAAGGAAGAG),
Lyn-r (TCTGACTGTGGTCCCATTGAGC),
Lyn-f (GATTGTCACCTATGGGAAGATTC),
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Csk-f (CGTTCGGTGCTAGGTGGAGAC),
Ctk-r (ACTATTTTGCGGAAGGGTGGTC),
Ctk-f (CGTGCTCTTGTGAGCACCTCTC),
GAPDH-r (CTTACTCCTTGGAGGCCATG),
GAPDH-f (TTAGCACCCCTGGCCAAGG).
For each gene, the linear amplification range was optimized.
Reactions were performed on a PCR cycler (GeneAmp, PCR
System 9700, PE Applied Biosystems) using cDNA (1.1 ng),
oligonucleotide primer (10 pmol each), of each dNTP (200 mM
each), SAWADY Taq-DNA-Polymerase (2 units, PEQLAB) and
1X reaction buffer S in a 50 ml volume. Amplification started with
a9 5 uC denaturation for 5 min, followed by the optimized number
of cycles of 95uC/30 sec, 55uC/30 sec, 72uC/1 min. The PCR
products were visualized by electrophoresis on 2% agarose gels in
TBE buffer (89 mM Tris-base pH 7.6, 89 mM boric acid, 2 mM
EDTA) with 10 mg/ml ethidium bromide and photographed using
a UV light box.
GEM-Preparation
To isolate glycosphingolipid-enriched microdomains, C57Blc6
mice brains were homogenized with ULTRA-TURRAX T25
(Janke & Kunkel GmbH, IKA-Labortechnik) and lysed at a
concentration of 1 g/3 ml in ice-cold Brij 58-containing lysis
buffer (3% Brij 58, 50 mM Hepes pH 7.4, 100 mM NaCl, 1 mM
AEBSF (AppliChem GmbH), 5 mM EDTA, 1 mM sodium
orthovanadate, 50 mM sodium fluoride, 10 mM sodium pyro-
phosphate) for 10 min on ice. Lysates were then subjected to
sucrose gradient centrifugation as previously described [14].
GEM-containing fractions were detected by dot blot probed with
biotinylated cholera toxin subunit B (Sigma) and streptavidin-HRP
(Dako A/S, Glostrup, Denmark).
Immunoprecipitation and Western blot analysis
Brain homogenates in GEM buffer were incubated with 1% N-
dodecyl b-D-maltoside [lauryl maltoside] (Calbiochem) for 30 min
on ice. After incubation, lysates were centrifuged for 15 min at
15,700xg. For direct Western blot analysis supernatants were
heated in 1x reducing sample buffer for 5 min at 95uC. For
immunoprecipitation, the postnuclear lysate was immunoprecip-
itated with the respective antibodies/-sera as previously described
[14]. Gel electrophoresis of immunoprecipitates and lysates as well
as ECL-Western blotting have also been described [14].
In vitro-kinase assays
Fyn and Src were immunoprecipitated from pooled GEM-
containing fractions following incubation with 2% lauryl-maltoside
for 30 min on ice and centrifugation for 15 min at 15,700xg at
4uC, using either 0.5 ml Fyn 02 and 30 ml protein A sepharose; or
4 ml anti-Src, 1 ml rabbit-anti-mouse (Dako) and 30 ml protein A
sepharose in the presence of 1 mg/ml BSA for 18 h at 4uC with
gentle rotation. Immunoprecipitates were washed and subjected to
the kinase reaction as previously described [14]. Samples were
separated by 10% SDS-PAGE, dried and exposed to film at –70uC
with intensifying screen and on Phosphoimager plates. Quantifi-
cation from films and phosphoimager plates yielded the same
results.
PAG constructs
To express N-terminally Flag-tagged PAG, an oligonucleotide
containing the CD8a leader sequence (aa 1–21) and FLAG tag was
ligated into pGEM-5Zf vector using the Aat II-Nco I sites. The
PAG sequence was then inserted at the Nco I-Not I site. The Flag-
tagged PAG was excised from the pGEM vector and inserted into
pEF-IRES using Sma I-Not I ligation. The Nhe I site within the
CD8-Flag tag was used for screening the colonies. Sequence
integrity was verified by sequencing (GATC Biotech). Stop
mutants were generated using the Quick-change site directed
mutagenesis kit II (Stratagene) following the manufacturers
instructions. The primer sequences used were:
STOP1-f (ACAGCATAGTGGGGACCATTAGAACCTGAT-
GAACGTGC),
STOP1-r (GCACGTTCATCAGGTTCTAATGGTCCCCAC-
TATGCTGT),
STOP2-f (GATCTGCTGGATTCCTAGGACAGCACAGG-
GAAAC),
STOP2-r (GTTTCCCTGTGCTGTCCTAGGAATCCAGCA-
GATC),
STOP3-f (CGTCAAAGTGTTAATGTATAGAGTATCCTT-
GG AAATTC),
STOP3- r (GAATTTCCAAGGATACTCTATACATTAACAC-
TTTGACG),
STOP4-f (GCTACTGTTAAAGACTTCTAAAAAACTCCA-
AACAGCAC),
STOP4-r (GTGCTGTTTGGAGTTTTTTAGAAGTCTT-
TAACAGTAGC).
Results
Developmental expression of PAG in brain
The function of PAG was first defined as a Csk-binding protein.
However, Csk expression in brain is strongly developmentally
regulated and expression in adult brain was reported to be limited
to the olfactory bulb [27]. Therefore, we tested the mRNA
expression of PAG as well as candidate interaction partners at
different stages in mouse brain development. Time points were
chosen to reflect early embryonal Csk expression at a time when
the embryos head can first be separately analyzed (E12), the peak
of Csk expression (P1), myelinating juvenile brain (P42), and adult
brain (P60). RT-PCR analysis (Fig. 1A) shows that PAG is
expressed at all of these time points. We confirm that Csk
expression peaks around P1, but contrary to previous reports [27]
we show considerable expression in juvenile and adult brain. In
agreement with previous work, we demonstrate that the expression
of the Csk-homologous kinase CHK is regulated opposite to that
of Csk with expression detected from P1 onwards, while Fyn is
expressed throughout. We now focused our analysis on postnatal
and adult brains as these time points showed the strongest
differences in Csk-expression, as well as in 6 week old brains,
where Fyn activity is important for proper myelination [4].
Western blot analysis (Fig. 1B) shows that PAG protein expression
is strongest at P1 whereas it is decreased in 6 week and 3 month
old brains. Csk protein expression is strong at P1, but hardly
detectable at 6 weeks and 3 months, while CHK expression
remains strong throughout. Fyn expression is well visible at P1 and
decreases slightly at the later time points, while expression of Src
remains fairly constant. Interestingly, phosphorylation of Y529,
the negative regulatory site within SFKs phosphorylated by Csk
and CHK, is very high at P1 and is much weaker at the later time
points. This difference cannot simply be explained by changes in
the expression levels of Fyn and Src, but fits rather well with the
higher expression of Csk and CHK at P1.
Localization of PAG expression in postnatal and adult
mouse brain
As postnatal and adult mouse brain showed striking differences
in the levels of Csk and, to a lesser extent, PAG expression, we
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differed at these time points. Measuring the mean density in
autoradiographs we found that overall expression of PAG-mRNA
in adult brains was 50% of that in P1 brains (Fig. 2), correlating
well to the difference in protein expression (Fig. 1B). At both ages,
a neuronal expression pattern dominated. At P1, PAG-mRNA
expression was high in most areas of gray matter, namely cerebral
cortex, hippocampus, septal nuclei, habenula, olfactory bulb, and
striatum. In adult mouse brain PAG-mRNA expression was
concentrated in the limbic system and in cerebellum. The highest
expression levels were found in the hippocampus, particularly in
the CA3 area and the dentate gyrus (Fig. 3), in the septal nuclei,
medial habenula, and the pineal gland. Furthermore, cerebellar
cortex showed a striking expression in the Purkinje cell layer.
Intermediate expression levels were found in cerebral cortex,
thalamus, and olfactory bulb, particularly in the mitral cell layer
and inner granule cell layer. Brain stem showed a lower PAG
expression and no particular nuclei could be delineated. In spinal
cord, PAG-mRNA was concentrated in gray matter and
expression showed a gradient towards higher expression in the
dorsal horns (not shown). White matter showed a low expression of
PAG-mRNA, which nevertheless exceeded background levels.
PAG binding partners
Within the immune system, the binding and recruitment of Csk
into lipid rafts, thereby regulating the activity of Src family kinases,
has been defined as a crucial function of PAG. We show here, that
Y314 of PAG, the residue critical for Csk binding, is phosphor-
ylated with little difference in developing and adult brain (Fig. 4A).
Given the low expression of Csk and the specific localization of
PAG expression in adult brain, we tested whether Csk can still be
found associated at this time point. We could readily reproduce
Csk-binding to PAG at P1; at 6 weeks and 3 months very little Csk
can be co-precipitated. As the SH2 domain of CHK is highly
homologous to Csk and CHK expression, contrary to Csk,
increases during brain maturation, we tested whether CHK can
also associate to PAG. Using both a polyclonal anti-CHK-serum
and a monoclonal anti-CHK-antibody, we could co-precipitate
CHK with PAG in developing and adult brain. As both Csk and
CHK run at similar molecular weights and the overall homology
between both proteins is ,50% (this is also true of the C-terminal
100 amino acids to which the antibodies were generated) the
specificity of our antibodies was tested in Csk-and CHK
immunoprecipitates, where no cross-reactivity was shown
(Fig. 4B). Furthermore, both the anti-CHK-antiserum and the
anti-CHK–antibody did not cross-react with mouse Csk overex-
pressed in HEK-293 cells. Thus, we can demonstrate a specific
association of CHK to PAG in mouse brain.
PAG has been shown to be phosphorylated by Src kinases,
particularly Fyn. In brains of postnatal Fyn-deficient mice a
reduced total tyrosine phosphorylation of PAG was shown [20],
however, the binding of Fyn to PAG in CNS cells or tissue has not
been demonstrated to date. We show that in postnatal, 6 week,
and three month old brains Fyn is associated to PAG. Moreover,
we demonstrate the binding of Src in developing and mature brain
(Fig. 4A).
We could not detect an association of Lyn to PAG in our whole
brain extracts (data not shown), which had been demonstrated in
mast cells [18]. However, this may be explained by the lower
expression levels of Lyn during development and its specific
concentration in the cerebellum.
PAG contributes to the recruitment of Csk to lipid rafts in
postnatal brain
To analyze PAG function, we generated Pag1-knockout mice by
homologous recombination as described in the Materials and
Methods (Fig. S1). Pag1-knockout mice are negative for the PAG
protein (Fig. 5 and Fig. S3). Note that additional bands appear in
Western blots from 3 month old wild type and Pag1
-/- brains that
are recognized by our antiserum (Ig452), however these bands are
peptide-unspecific (Fig. 6B) and thus do not represent PAG. Using
an antiserum against the N-terminal peptide (P18, 1–18) and a
different antiserum against the cytoplasmic domain (Rabbit anti-
PAG, 97-432) we could also not detect a truncated protein (Fig.
S3). Pag1
-/- mice had no alteration in birth weight, showed no
Figure 1. Expression of PAG during brain development. A) Total
RNA was isolated from whole C57Bl6 mouse brains (head or whole
embryo for E12) of different ages as indicated. The expression of PAG-
mRNA and functionally related genes was analyzed following an RT-
reaction and PCR using gene-specific primers. CHK-RT-PCR produced a
band at the expected molecular weight (460 bp) as well as a much
weaker band at 560 bp. Sequencing revealed that the latter band
represented an incompletely spliced product including intron 10. One
representative out of three similar experiments is shown. B) Expression
of PAG and functionally related proteins was analyzed by Western blot
from whole brain lysate of postnatal C57Bl6 mice of different ages as
indicated. PAG was detected here with the antiserum against the whole
cytoplasmic domain. Detection with the anti-PAG peptide antiserum
Ig452 resulted in a similar signal. As all structural proteins tested
showed differential expression during development, equal loading was
assured by determination of protein concentration (50 mg/lane) and
controlled for by Coomassie staining of the gels (not shown). A double
band for CHK at P1 was consistently shown with both a polyclonal anti-
CHK-antiserum and a monoclonal antibody against this protein and
may represent two different isoforms or phosphorylated forms. A
similar double band has previously been shown in Western blot [55].
One representative out of four similar experiments is shown.
doi:10.1371/journal.pone.0023978.g001
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with the oldest animal in our colony now reaching 2.5 years.
PAG predominantly localizes to lipid rafts in lymphocytes and
postnatal mouse brain [14,20]. We confirm that the majority of
PAG is found in the lipid raft fractions in postnatal brains (Fig. 5A).
In adult brains, lipid rafts are consistently found one fraction lower
than at P1, probably due to the high lipid content of myelinated
brain. However, rafts can clearly be isolated, demonstrated by the
binding of cholera toxin to GM1-lipids. Similar to P1, PAG
strongly associates with the lipid raft fractions (Fig. 5B).
The Src family kinases Fyn and Src are found both inside and
outside of lipid rafts, as previously described [20]. Interestingly,
while the majority of Fyn is localized to the lipid rafts in both
newborn and adult brain, only a minor proportion of Src is raft-
associated in newborn murine brain. In adult brain the
distribution of Fyn and Src is similar. Notably, given the
association of PAG with Fyn or Src in wild type-animals
(Fig. 3), neither the distribution of Fyn nor Src is altered in the
brains of Pag1-deficient mice (Fig. 5A and B, 6A). We next
investigated whether the localization of Csk is altered in the
brains of Pag1-knockout mice. We found that the amount of Csk
within GEMs is reduced to 25 % of wildtype in P1 Pag1
-/- brains.
(Fig. 5A, 6A, p,0,05). In agreement with this finding, the
phosphorylation of the inhibitory tyrosine Y529 in Src/Fyn
within GEMs, which is dependent upon Csk or CHK, is reduced
to 35% in postnatal (P1) brains of Pag1-deficient mice (Fig. 5A,
6A, p,0.05). Note that the majority of the pY529 signal is found
within the lipid rafts in both postnatal and adult animals.
However, the amount of Csk that can be detected in lipid rafts of
adult wild type mice is minute. Interestingly, the amount of lipid
raft-associated Csk does not appear to differ in adult Pag1-
knockouts (Fig. 5B and 6B). Phosphorylation of Y529, which is
generally much lower than in newborn mice, is also unchanged in
lipid rafts of adult knockout animals (Fig. 5B and 6B). Despite its
association to PAG in wild type mice, the distribution of CHK is
not altered in either newborn or adult Pag1
-/- mice (Fig. 5A, B,
and 6A, B).
To compare total expression levels and tyrosine phosphoryla-
tion, we investigated whole brain lysate of wild type and Pag1
-/-
mice (Fig. 7). Pag1-deficiency (Fig. 7A) did not lead to a change in
the expression of Csk and CHK or the Src-kinases Fyn and Src in
either postnatal or adult brain (Fig. 7B). In postnatal brain
however, phosphorylation of the inhibitory tyrosine in SFKs was
reduced by 42% in knockout mice (analyzed over 4 independent
experiments), paralleling the reduction of Csk in the lipid raft
fractions (Fig. 7B and C). In brain lysate of adult mice, a trend to a
reduction of around 14% in the pY529 signal is observed, which is
not significant on statistical testing (p=0.18), indicating at least a
partial compensation for the lack of PAG during brain maturation
(6 independent experiments; Fig. 7C).
Figure 2. In situ distribution of PAG transcripts. Film autoradiographs of horizontal mouse brain sections showing PAG mRNA distribution in A)
adult and B) postnatal (P1) mice. The respective sense controls are shown below (C, D). In the adult brain most prominent mRNA expression was
detectable in septum (S), medial habenula (MHb), thalamic nuclei (Th), hippocampus (Hi), and cerebellum (Cb). One representative out of two similar
experiments is shown.
doi:10.1371/journal.pone.0023978.g002
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To test whether the decreased phosphorylation of the inhibitory
tyrosine is associated with increased kinase activity in postnatal
Pag1
-/- mice, we next performed in vitro kinase assays for Fyn and
Src from whole brain lysates. No difference was observed (data not
shown). However, as PAG is predominantly found within the rafts,
we hypothesized that it might exert its regulatory function only on
a subset of SFKs. Thus, when the Src kinases were precipitated
from the lipid rafts, Pag1
-/- mice showed an increase in both auto-
and substrate phosphorylation. The basal activity of Fyn was
increased by 50% (p,0,05), Src activity showed a similar trend,
however the result was not significant (p=0.31) (Fig. 8A, C). This
corresponded well to a 40% decrease of Y529 phosphorylation,
which was significant in both Fyn- and Src-immunoprecipitates
(Fig. 8E). To our surprise, adult Pag1
-/- brains showed the reverse
phenotype with a decrease in basal Fyn and Src kinase activity of
220% and 228%, respectively (p,0.05 and p,0.01, resp.,
Figure 3. Localization of PAG transcripts in specific regions of adult brain. Representative dark-field micrographs (A, C, E, G, I, L)
illustrating the hybridization and the respective bright-field (B, D, F, H, K, M) micrographs in adult mouse brain. Pictures are taken from horizontal
sections, with the exception of L and M, which are photographed from frontal sections. A, B) Septal nuclei (SepN), C, D) habenula (MHb), E, F)
hippocampus: CA2 and 3 and dentate gyrus (DG), G, H) cerebellum (ML: molecular layer, Pu: Purkinje cell layer, GL: granular cell layer), I, K) thalamus
(Th), L, M) pineal gland (PG). Scale bar 200 mm.
doi:10.1371/journal.pone.0023978.g003
Figure 4. Binding partners of PAG in postnatal and adult brain. A) PAG immunoprecipitates from whole brain lysates of newborn, 6 month
old, and adult mice were analyzed by Western blot. Each association was shown in at least three independent experiments. B) Csk and CHK were
immunoprecipitated from lysates of adult mouse brain. Western blot analysis with CHK and Csk-antibodies, respectively, reveals no cross-reactivity. C)
HEK-293 cells were transfected with a mouse-Csk-CFP construct versus vector containing CFP alone. Over-expression is demonstrated with the anti-
Csk-antibody. There is no cross-reactivity of the anti-CHK-antibody with the over-expressed Csk. Csk-CFP is indicated with an arrow, endogenous Csk
with an asterisk.
doi:10.1371/journal.pone.0023978.g004
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Y529 phosphorylation (Fig. 8F), indicating a net change of 70–
80% in kinase activity within three months. The phosphorylation
of other regulatory tyrosines (Y418, Fyn Y215) was not altered in
adult Pag1
-/- brains (data not shown). As a possible substitute for
PAG in brain we explored LIME, another lipid-raft-associated
Csk-binding phosphoprotein with adaptor function [28,29].
Although in situ-hybridisation data suggest that LIME is indeed
expressed within this organ (http://www.brain-map.org), we were
unable to confirm protein expression in mouse brain due to strong
cross-reactivity of our antibodies/-sera. However, LIME is
unlikely to function as the main compensator for the lack of
PAG as Lime1
-/-/ Pag1
-/- double knockout mice are viable and
fertile (J. Lindquist, unpublished observation). Another lipid-raft –
bound Fyn-substrate, which phospho-dependently binds Csk, is
PSD93, an important component of neuronal postsynaptic
densities [30]. Belonging to the family of membrane-associated
guanylate kinases, PSD93 also functions as an adaptor. We
showed increasing expression in the first postnatal weeks (Fig. 9A).
Furthermore, in adult brain a greater proportion of the cellular
PSD93 is localized in lipid rafts of WT and Pag1
-/- mice (Fig. 9B).
At 3 months a much stronger association to Csk compared to P1
could be found (Fig. 9C). After repeated immunoprecipitation of
PSD93 from GEMs, Csk was also reduced (Fig. 9D), indicating
that PSD93 binds Csk within the GEMs and can recruit Csk to the
membrane possibly substituting for PAG in the brains of older
mice. Note, PSD93 can be co-precipitated with Csk in abundance,
while the Csk-PAG-association can in our hands only be shown via
immunoprecipitating PAG, not vice versa. Therefore, one roles of
PSD93 in adult WT mice might be the recruitment of Csk, and the
amount of PSD93 that could be additionally bound to Csk to
substitute for PAG in adult Pag1
-/- mice may not be detectable
(Fig. 9E).
SH2-dependent binding of Fyn to PAG may lead to an
active conformation
The surprising finding that SFK activity is decreased in the
absence of PAG lead us to hypothesize that one function of PAG
may be to keep Src kinases in an open conformation. Thus we
investigated the Fyn binding site in PAG. We constructed several
N-terminally tagged STOP-mutants of PAG (Fig. S4) and
expressed them in HEK 293T cells (Fig. S3). Membrane targeting
of the STOP mutants is shown in Fig. S5. In vitro kinase assays
demonstrated that Fyn kinase activity was associated with WT
Figure 5. Reduced Csk-recruitment to lipid rafts in P1- Pag1
-/- mice. Whole brains from A) P1 wild type C57Bl6 (WT) and Pag1
-/- mice or B)3
month old WT/ Pag1
-/- littermate pairs were lysed in GEM-lysis buffer and subjected to sucrose-density centrifugation. Fractions were analyzed by
Western blotting. PAG was detected using the Ig452 antiserum. Lipid raft fractions were identified by binding of cholera toxin subunit B (Ctx) binding
to GM1-lipids in a dot blot from the fractions. * Arrowheads indicate non-specific bands in 3 months old Pag1
-/- and wild type brain extracts, see also
Fig. 6A.
doi:10.1371/journal.pone.0023978.g005
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kinase activity was not seen with either STOP1 or STOP2, which
lack the N-terminal proline rich region (Fig. S4B). Previously, the
PAG-Fyn-association was proposed to be constitutive, mediated by
the Fyn-SH3 domain [14], however, a contribution of the SH2-
domain was suggested [14,31]. To confirm this result, Fyn
immunoprecipitates were performed from transfected cells and
probed with anti-Flag (Fig. S4C). Surprisingly, Fyn binding is
observed with all mutants, except STOP 1, indicating that Fyn can
also bind to Y105. Together these results identify the membrane
proximal proline-rich region and Y105 as potential binding sites
for the SH3 and SH2 domains of Fyn, respectively. Binding of the
Fyn SH2-domain to PAG may prevent the intramolecular binding
of the C-terminus, when phosphorylated at the inhibitory tyrosine.
By this mechanism, PAG may prevent SFKs from adapting the
closed inactive conformation.
Discussion
Src family kinases regulate multiple processes in brain
development and function, such as neuronal survival, differenti-
ation, migration, and axonal path finding, as well as synaptic
plasticity. Here we describe the transmembrane adaptor PAG as a
novel component in the regulatory circuits of Fyn and Src activity
in the brain. We identify lipid rafts as the platform where negative
regulatory tyrosine phosphorylation of SFK takes place and show
that the correct localization of regulatory components to lipid rafts
is a prerequisite for proper SFK-signaling in the brain. We
demonstrate differential PAG expression patterns in postnatal and
adult brain and show that mechanisms of SFK regulation differ
dependent on maturation.
Within the immune system, PAG has been established as an
important negative regulator of Src kinase activity [14,20,32].
Therefore, Pag1-knockout mice were predicted to have a severe
phenotype, comparable to Csk-deficient mice [33]. Surprisingly,
they turned out to be viable and healthy [34,35]. Having found no
difference in lymphocyte development and function, both groups
concluded that in their system PAG was dispensable as a regulator
of SFKs. However, our recent study employing RNA interference
to down-regulate PAG expression clearly demonstrates that in the
absence of PAG, Src-kinases are hyperactive, thus suggesting that
the Pag1-knockout mice had developed a compensatory mecha-
nism [23]. Here we analyze a third Pag1-knockout strain, focusing
on a different organ with abundant PAG-expression, the brain.
Brain provides an advantageous experimental system as firstly, Csk
is absolutely required for brain development. Mice deficient for
Csk show a dramatic increase in SFK activity and are embryonic
lethal due to neural tube defects and massive neuronal apoptosis
[12,13]. Secondly, postnatally Csk-expression declines sharply,
suggesting that other mechanisms of SFK regulation gain
importance. In postnatal brain we can demonstrate the expected
phenotype for Pag1-deficiency, i.e. reduced phosphorylation of the
inhibitory tyrosine (Y529) in Fyn and Src correlating with a
marked reduction of Csk-recruitment into lipid rafts, which is most
likely enhanced by the lack of stimulation in Csk activity that
normally results from PAG-binding [36]. In agreement with our
study, Xu et al. showed reduced Csk-recruitment to lipid rafts, but
did not explore the effects on regulatory tyrosine phosphorylation
Figure 6. Quantification of kinases in GEM gradients. The kinase bands in each fraction represented in Fig. 5 were quantified from three
independent experiments for A) the P1 and B) the 3 month time point.Thesummative signal from GEM fractions in relation to the total signal is presented
as ratio to wildtype for each kinase. GEM containing fractions were determined by choleratoxin staining. For phosphotyrosine 529 the total signal in GEMs
and the total signal on the blot are given in separate graphs, as most of the signal localizes to GEM fractions and the total amount of pY529 is reduced in
PAG1
-/- mice (see also Fig. 6). Given are the means +/2 SEM. Np,0.05, Student’s t-test, all other pairs did not show significant differences.
doi:10.1371/journal.pone.0023978.g006
Figure 7. Decreased phosphorylation of Src-kinase negative-
regulatory tyrosine 529 in P1- Pag1
-/- mice. For P1-material, protein
extracts were prepared from separate newborn litters of time-mated Pag1
-/-
mice and wild type C57Bl6 mice. For 3 months-material, protein extracts
were prepared from adult Pag1
-/- a n dw i l dt y p el i t t e r m a t e so fPag1
+/-
crossings. A)I n c u b a t i o nw i t ha n t i - P A G - a n t i s e r u mI g 4 5 2d e t e c t sab a n da t
75-80 kDa in brain extracts of 3 month old Pag1
-/- mice. Co-incubation with
the antigenic peptide abolished the specific PAG-band in WT mice, but left
the additional band unchanged in both WT and Pag1
-/- extracts, indicating
that this band is not peptide-specific. B) Equal concentrations of protein
from each sample were analyzed by immunoblotting for PAG (Ig452), Csk,
CHK, pY529, Fyn, and Src. Actin staining served as loading control. C)
Phosphorylation of the negative regulatory tyrosine (pY529) was quantified
in different experiments and is presented as the ratio to wild type. Mean
and SEM are given for n=4 (P1) and n=6 (3 months) independent
experiments. ** p,0.01, n.s. not significant, Student’s t-test.
doi:10.1371/journal.pone.0023978.g007
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Although both studies analyzed similar cells, methodological
differences, e.g. in lipid raft preparation, may account for the
dissimilar results. We demonstrate that SFKs phosphorylated at
Y529 reside predominantly within the lipid rafts, indicating that
the enzyme responsible for phosphorylating this tyrosine, Csk or
CHK, needs to be recruited to this membrane compartment. The
functional importance of the lipid raft localization of Csk is
illustrated by our recent study of a mutant PAG molecule lacking
the palmitoylation motif, which localizes to the membrane, but not
to lipid rafts. Here, Csk is accumulated outside of rafts resulting in
a prolonged Src kinase activation upon stimulation and an
enhanced migration of these cells in response to chemokine [37].
Now we show, in postnatal brain, that the decreased recruitment
of Csk into lipid rafts in Pag1
-/- mice results in a 50% increase in
SFK activity within lipid rafts, which correlates well with our
Figure 8. Src kinase activity is altered in both postnatal and adult Pag1
-/- brain. GEM-containing fractions (identified via cholera toxin
subunit B-binding) of A) postnatal or B) adult wild type and Pag1
-/- brains were pooled, 10% was retained for a Western blot control, the rest was split
into two samples, from which Fyn and Src, respectively, were precipitated. Precipitates were again split in halves and subjected to either in vitro
kinase assay (upper panels) or Western blot (lower panels) which controlled for equal amounts of kinase precipitated. C) and D) Kinase activities are
presented as ratio to wild type. E) and F) Phosphorylated Y529 was quantified in the Western blot controls of Fyn and Src immunoprecipitates and
normalized to the amount of precipitated SFK. Given are the means +/- SEM, n= number of independent experiments. p,0.05, ** p,0.01, n.s. not
significant, Student’s t-test.
doi:10.1371/journal.pone.0023978.g008
PAG Modulates SFK Activity in Brain
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e23978observation of a 40% decrease in the phosphorylation of the
inhibitory tyrosine. The demonstrated increase in kinase activity
may appear rather small compared to the Csk-knockouts where 4-
14 fold increases in specific activity were found. However, these
values were counter-balanced by a dramatic downregulation of the
expression levels of Fyn, Src, and Lyn. The resulting net increase
in active kinase nevertheless proved deleterious [12,13],
emphasizing the importance of tightly regulating Src-kinase
activity. In our Pag1
-/- mice neither the expression levels of Fyn
and Src nor their lipid raft association were altered, thus exposing
the cells to a 50% net increase in SFK activity. Interestingly, mice
deficient in protein tyrosine phosphatase a (PTPa), which counter-
regulates Csk activity, show a 50% increase in the phosphorylation
of Y529 and a 50–60% decrease in Src and Fyn activity [38]. In
Figure 9. Developmental expression and Csk-binding of PSD93. A) Whole brain lysates from WT mice of the indicated ages were Western
blotted and stained for PSD93. B) Brains of P1 wild type and Pag1
-/- mice and 3 month old WT/ Pag1
-/- littermate pairs were lysed at concentrations of
3 ml/g and 4.5 ml/g, respectively, in GEM-lysis buffer and subjected to sucrose-density centrifugation. Fractions were analyzed by Western blotting
and staining for PSD93. Lipid raft fractions were identified by binding of cholera toxin subunit B (Ctx) binding to GM1-lipids in a dot blot from the
fractions. C) Densitometric quantification of the PSD93 signal in GEM-fractions as percentage of the total PSD93-signal. For both time points, the
PSD93 signal in fractions 2-5 was expressed as a ratio to control. This most likely overestimates the lipid raft localized material in P1, as only fraction 2
and 3 contain rafts (n=3 independent experiments for each time point) D) Csk-immunoprecipitates from whole brain lysates of WT mice (ages as
indicated), stained for PSD93 and Csk. Densitometric quantification of the relative amount of PSD93 bound to Csk in brains of P1 and 3 month old
mice (n=3 independent experiments) E) Csk-immunoprecipitates from whole brain lysates of 3 month old WT and Pag1
-/- mice stained for PSD93
and Csk. Two exposures are given for the PSD93-signal in the left panel. Comparison of whole brain lysates of 3 month old WT and Pag1
-/- to P1.
Given are the means +/- SEM, n.s. not significant, Student’s t-test.
doi:10.1371/journal.pone.0023978.g009
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mice still present with a subtle neurological phenotype including
reduced spatial learning, locomotor activity, and anxiety [39].
Considering that Csk inhibits all Src kinases, a 50% increase of
basal SFK-activity particularly in GEMs may be of similarly subtle
phenotypic consequence.
In P1 brains, the function of PAG is closely connected to Csk
recruitment. We show that in adult brain although PAG is
abundant, Csk concentrations are minimal and very little Csk is
bound to PAG. We demonstrate the binding of the second
negative-regulatory tyrosine kinase, CHK, which is more strongly
expressed postnatally, to PAG, pointing to a broader role for PAG
in the regulation of SFK in the central nervous system. The
observation of a phospho-dependent interaction of CHK with
PAG [40] supports our results. However, a CHK association to
PAG in brain may also be indirect, e.g. via the association of CHK
to SFK or transmembrane receptors [41]. The finding of
unchanged expression levels of CHK and unaltered distribution
within lipid rafts in our Pag1-deficient mice demonstrates firstly,
that CHK does not compensate for the reduced recruitment of
Csk and secondly, that PAG is dispensable for CHK localization to
this membrane compartment in brain.
In adult brain, PAG expression overlaps with the localization
reported for both Fyn and Src, specifically the brain-specific
isoform pp60 c-src(+), in the hippocampus and the dentate gyrus,
as well as in the olfactory bulb and the cerebellum. Interestingly,
the specific concentration of PAG in the septal nuclei, habenula,
and pineal gland is also shared with pp60 c-src(+) [42].
Furthermore, we could show for the first time the binding of
Fyn and Src to PAG in primary tissue. The shared expression
pattern and close association of PAG and SFKs in a situation
where little Csk is expressed lead us to explore whether PAG has a
role for the regulation of SFKs beyond Csk-recruitment.
In contrast to the situation in P1 postnatal brains, no alteration
in the subcellular distribution of Csk was detectable within the
brains of adult Pag1
-/- mice. Consequently, there was also no
significant decrease in Y529 phosphorylation of Fyn or Src. There
was no counter-regulation in the level of Csk or CHK expression.
The surprising finding of a 20–30% decrease of Fyn and Src
activity in brains of Pag1-deficient mice indicates that compensa-
tory mechanisms are strengthened during brain maturation. The
lipid raft-resident adaptor PSD93 may in part substitute for PAG
in adult brain. We show a strong increase in PSD93 expression,
lipid raft association, and binding to Csk postnatally. We
demonstrate that PSD93 binds Csk within lipid rafts and that by
immunodepleting PSD93, Csk can also be markedly reduced,
indicating that PDS93 can recruit Csk to lipid rafts. Other
candidates for Csk recruitment to lipid rafts in adult brain are
paxillin [43,44], caveolin-1 [45], and ZO-1/2 [46].
Restored Csk-recruitment however, does not explain the
decrease in Src and Fyn activity observed in the brains of adult
Pag1
-/- mice. We do not observe increased Y529 phosphorylation,
therefore an upregulation of Csk activity, e.g. by cAMP dependent
protein kinase (PKA)-induced phosphorylation of Csk [47] or any
other PAG-independent role of Csk, is unlikely to contribute to the
compensatory mechanism. Unaltered Y529 phosphorylation in
adult knockout mice also excludes compensation through PTPa.
Counter-regulation affecting Y418 within the activation loop may
be postulated. However, in accordance with the previous analysis
of Pag1
-/- mice [34], we did not find any alteration in the
phosphorylation levels of this tyrosine residue. Greatly enhanced
kinase activity can also follow phosphorylation of Src Y215,
particularly in the presence of inhibitory tyrosine phosphorylation
[10]. We have shown recently that not only increased Src, but also
increased Fyn kinase activity is associated with Y215 phosphor-
ylation [23]. Again, we did not find any difference in the levels of
pY215 between the brains of wild type and Pag1
-/- mice. Finally,
SFK activity can also be enhanced by stabilizing an open/active
conformation of the Src kinases [48,49]. We show here that the
binding of Fyn to PAG involves the first proline-rich region as well
as Y105 in PAG, thus confirming the findings of Solheim et al.
[50]. This group recently demonstrated that PAG-binding
enhances Fyn kinase activity in vitro and suggested that the binding
of the Fyn SH2 domain to PAG prevents the intramolecular
binding with its phosphorylated C-terminus, thereby maintaining
an open/active conformation. Additionally, the ‘free’ phosphor-
ylated C-terminus may then function as a binding site for other
SH2-domain-containing proteins, such as STAT3, as we have
recently shown [51]. Support for a positive regulatory function of
PAG is also provided by the study of Davidson et al. [32]. In
transgenic animals overexpressing a mutant form of PAG lacking
the Csk binding site, SFK activity following TCR stimulation is
enhanced. The phenotype of our adult Pag1
-/- mice and the small
regional overlap in expression of PAG and Csk supports such a
Csk-independent positive regulatory role for PAG in adult brain.
PAG has been shown to influence SFK signaling independent of
Csk by sequestering SFKs into lipid rafts [52] and by altering the
levels of GM1 in rafts [53]. In our Pag1
-/- mice the lipid raft
localization of Fyn or Src was not altered, however, the
recruitment of other signaling components into the lipid rafts
should be investigated. Apart from forming a binding site for Csk,
PAG possesses nine other tyrosine residues that are potential
binding sites for adaptors such as Shc and Grb2, as well as
enzymes like Lck, Fyn, Lyn, ZAP-70, Shp-1, Shp-2, PI3K,
RasGAP, and Vav [14]. Furthermore, we have recently identified
a multiprotein complex containing RasGAP and Sam68, which
links PAG to both the regulation of Ras [23] and possibly to
nuclear-dendritic feedback [54].
While our biochemical analysis focused on quantitative changes
in whole brain extracts, further studies need to delineate cell-type-
specific effects of PAG deficiency and the consequences for brain
function, e.g. for the processing of strong emotions, learning, and
memory, for which those structures with high expression levels of
PAG, septum, habenula, and hippocampus, are central.
Supporting Information
Figure S1 Antibodies against PAG, Fyn and Src work
phospho-independently. Jurkat T cells were either left
unstimulated, incubated with 10 mM PP2, a Src kinase inhibitor,
for 30 min to reduce phosphorylation, or treated with pervanadate
to maximize phosphorylation. Equal cells numbers were lysed and
then protein concentrations determined to ensure equal loading.
The cell lysates were the separated by SDS-PAGE and transferred
onto nitrocellulose membranes. Western blots were performed
with the indicated antibodies (PAG[Ig452], Rabbit anti-PAG,
Fyn-02, and Src [clone GD11]). Additionally, pan-phosphotyr-
osine [4G10] staining was performed to verify successful treatment
of the cells, Grb2 was included as the loading control.
(TIF)
Figure S2 Generation of Pag1-knockout mice. A) Struc-
tures of the wild-type gene and mutant gene. B) PCR results using
primers indicated in A show correct integration at the 59 and the 39
sites. C) Restriction digestion of DNAs from wild type (WT) and
mutant BACs. D) Fluorescence in situ hybridization analysis of cell
lines confirms successful targeting in clones 7 and 35.
(TIF)
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PAG [P18] confirm that no PAG protein is expressed in
Pag1-knockout mice. Whole brain lysates from P1 wild type
and Pag1
-/- mice were subjected to sucrose-density centrifugation.
Fractions were analyzed by Western blotting. PAG was detected
using the Rabbit anti-PAG (97-432) antiserum or the anti-PAG
[P18] serum recognizing the N-terminal part of the protein. No
full length or truncated PAG protein could be detected. The
asterisk indicates the gel front, the arrowheads point to unspecific
bands in WT and KO, which run at a different MW and in the
heavy fractions, contrary to PAG.
(TIF)
Figure S4 Fyn binding site in PAG. A) Truncation mutants
generated from N-terminally Flag-tagged PAG. The black triangle
represents the epitope tag, the transmembrane region (TM) is
indicated with an unfilled box, the palmitoylation motif is
indicated with asterisks, and filled boxes indicate the proline rich
regions (PRO). The numbers represent the location of tyrosine
residues with PAG. B) Autoradiograph from in vitro kinase assays
performed on Flag-immunoprecipitates from transfected HEK
293T cells. The Fyn immunoprecipitate is included as a control.
C) Fyn immunoprecipitates from HEK 293T cells transfected with
the indicated constructs. Western blots were stained with rabbit-
anti-Flag. The bands at 55 and 25 kDa are the heavy and light
chains of the immunoprecipitating antibody. D) Expression of the
PAG constructs. Rabbit-anti-Flag staining of post-nuclear cell
lysates from HEK 293T cells transfected with the indicated
constructs. Apparent molecular weight (kDa) is indicated to the
right.
(TIF)
Figure S5 Membrane localisation of the PAG con-
structs. Jurkat T- cells transfected with the indicated constructs
were stained with rabbit-anti-Flag/donkey-anti-rabbit-FITC and
mouse-anti-CD29/donkey-anti-mouse-Cy5 antibodies.
(TIF)
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